Literature DB >> 28748409

Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.

Kátia Simone Cezário de Barros1,2, Cristina Flores3, Luciana Harlacher3, Carlos Fernando Magalhães Francesconi3.   

Abstract

BACKGROUND: The phenotypic expression of Crohn's disease may vary over time. Establishment of Crohn's disease phenotypes is important for definition of patient care strategies. AIMS: The aim of the study was to evaluate the long-term evolution of patients based on disease phenotypes and the main factors associated with this evolution.
METHODS: Data from 179 patients were collected from a unicentric prospective database. Montreal classification was employed. Kaplan-Meier method was used to estimate the cumulative probability of complication development and surgery. Poisson regression for multivariate analysis was applied. The Local Institutional Review Board approved the research.
RESULTS: Female: 54.2%. Mean age at diagnosis: 32.7 (±13.7) years. Behavior at presentation: inflammatory 62.0%, stricturing 24.6%, penetrating 13.4%; perianal disease: 31.8%; median follow-up time: 65.2 months (IQR 31.0-108.8). Behavior at follow-up period end: inflammatory 43.6%, stricturing 38.0%, penetrating 18.4%; perianal disease: 46.4%. Cumulative probability of being complication free in 5, 10, and 20 years: 86.3, 66.4, and 52.2%, respectively. Cumulative probability of being surgery free in 5, 10, and 20 years: 87.3, 79.2, and 64.1%, respectively. L1 and L4 locations, use of immunosuppressive therapy, smoking, number of hospitalization/patient-year, abdominal surgery, age at diagnosis <40 years, and biological therapy were the factors associated with changes in phenotype or development of complications and perianal disease.
CONCLUSION: Clinical behavior altered in about one-third of patients. The most frequent complication was a change to stricturing pattern. Disease location, current smoker, immunosuppressive therapy use, hospitalization, and abdominal surgery were factors associated with an unfavorable clinical evolution.

Entities:  

Keywords:  Crohn’s disease; Crohn’s disease complication; Montreal classification; Surgery

Mesh:

Year:  2017        PMID: 28748409     DOI: 10.1007/s10620-017-4685-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Outcome of patients with nonstenotic, nonfistulizing Crohn's disease.

Authors:  Pilar Nos; Vicente Garrigues; Guillermo Bastida; Nuria Maroto; Marta Ponce; Julio Ponce
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

3.  Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification system.

Authors:  Dorothy K L Chow; Rupert W L Leong; Larry H Lai; Grace L H Wong; Wai-Keung Leung; Francis K L Chan; Joseph J Y Sung
Journal:  Inflamm Bowel Dis       Date:  2008-04       Impact factor: 5.325

Review 4.  Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.

Authors:  R Balfour Sartor
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-07

5.  Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activity.

Authors:  F T Veloso; J T Ferreira; L Barros; S Almeida
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

6.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

7.  Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.

Authors:  Kelvin T Thia; William J Sandborn; William S Harmsen; Alan R Zinsmeister; Edward V Loftus
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

8.  Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study).

Authors:  Magne Henriksen; Jørgen Jahnsen; Idar Lygren; Erling Aadland; Tom Schulz; Morten H Vatn; Bjørn Moum
Journal:  Scand J Gastroenterol       Date:  2007-05       Impact factor: 2.423

9.  Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study.

Authors:  Inger Camilla Solberg; Morten H Vatn; Ole Høie; Njaal Stray; Jostein Sauar; Jørgen Jahnsen; Bjørn Moum; Idar Lygren
Journal:  Clin Gastroenterol Hepatol       Date:  2007-12       Impact factor: 11.382

10.  Factors affecting outcomes in Crohn's disease over 15 years.

Authors:  Jacques Cosnes; Anne Bourrier; Isabelle Nion-Larmurier; Harry Sokol; Laurent Beaugerie; Philippe Seksik
Journal:  Gut       Date:  2012-03-02       Impact factor: 23.059

View more
  5 in total

1.  A watchful waiting approach for newly diagnosed Crohn's disease patients with an inflammatory phenotype.

Authors:  Sharif Yassin; Naomi Fliss Isakov; Yulia Ron; Nathaniel Aviv Cohen; Ayal Hirsch; Nitsan Maharshak
Journal:  Int J Colorectal Dis       Date:  2021-01-06       Impact factor: 2.571

2.  Differentiation of Isolated Small Bowel Crohn's Disease from Other Small Bowel Ulcerative Diseases: Clinical Features and Double-Balloon Enteroscopy Characteristics.

Authors:  Meng Niu; Zheng-Hao Chen; Meng Li; Xing Zhang; Chun-Xiao Chen
Journal:  Gastroenterol Res Pract       Date:  2022-05-30       Impact factor: 1.919

3.  Hereditary Nonpolyposis Colorectal Cancer in Association with Crohn's Disease and Lynch Syndrome: The Importance of a Strict Endoscopic Surveillance.

Authors:  Gustavo Drügg Hahn; Panu Wetwittayakhlang; Waqqas Afif; Talat Bessissow; Peter L Lakatos
Journal:  Case Rep Gastroenterol       Date:  2022-03-17

4.  Clinical and Demographic Profile of Inflammatory Bowel Disease Patients in a Reference Center of São Paulo, Brazil.

Authors:  Tarcia Nogueira Ferreira Gomes; Fabio Silva de Azevedo; Marjorie Argollo; Sender Jankiel Miszputen; Orlando Ambrogini
Journal:  Clin Exp Gastroenterol       Date:  2021-03-17

5.  Intestinal mucosa-derived DNA methylation signatures in the penetrating intestinal mucosal lesions of Crohn's disease.

Authors:  Yuan Li; Zhiming Wang; Xiuwen Wu; Gefei Wang; Guosheng Gu; Huajian Ren; Zhiwu Hong; Jianan Ren
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.